Frederic Gomez-Bertomeu
Overview
Explore the profile of Frederic Gomez-Bertomeu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
400
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez A, Gomez J, Martin-Loeches I, Claverias L, Diaz E, Zaragoza R, et al.
Antibiotics (Basel)
. 2024 Oct;
13(10).
PMID: 39452234
: Bacterial/fungal coinfections (COIs) are associated with antibiotic overuse, poor outcomes such as prolonged ICU stay, and increased mortality. Our aim was to develop machine learning-based predictive models to identify...
2.
Peraire J, Garcia-Pardo G, Chafino S, Sanchez A, Botero-Gallego M, Olona M, et al.
Eur J Med Res
. 2024 Apr;
29(1):223.
PMID: 38581072
Background: COVID-19 pneumonia causes hyperinflammatory response that culminates in acute respiratory syndrome (ARDS) related to increased multiorgan dysfunction and mortality risk. Antiviral-neutralizing immunoglobulins production reflect the host humoral status and...
3.
Sanchez A, Garcia-Pardo G, Gomez-Bertomeu F, Lopez-Dupla M, Foguet-Romero E, Buzon M, et al.
iScience
. 2023 Oct;
26(10):107948.
PMID: 37810253
The metabolic alterations caused by SARS-CoV-2 infection reflect disease progression. To analyze molecules involved in these metabolic changes, a multiomics study was performed using plasma from 103 patients with different...
4.
Paton B, Herrero P, Peraire J, Del Pino A, Chafino S, Martinez-Picado J, et al.
Front Immunol
. 2023 Jun;
14:1204661.
PMID: 37342334
Background: The pathological mechanisms of SARS-CoV-2 in humans remain unclear and the unpredictability of COVID-19 progression may be attributed to the absence of biomarkers that contribute to the prognosis of...
5.
Masip J, Jorba R, Lopez-Dupla M, Domingo P, Pacheco Y, Garcia-Pardo G, et al.
Int J Mol Sci
. 2022 Jul;
23(15).
PMID: 35897644
Nuclear magnetic resonance (NMR)-based advanced lipoprotein tests have demonstrated that LDL and HDL particle numbers (LDL-P and HDL-P) are more powerful cardiovascular (CV) risk biomarkers than conventional cholesterol markers. Of...
6.
Masip J, Rallon N, Yeregui E, Olona M, Resino S, Benito J, et al.
Front Immunol
. 2022 May;
13:822272.
PMID: 35514981
Long-term elite controllers (LTECs) are a fascinating small subset of HIV individuals with viral and immunological HIV control in the long term that have been designated as models of an...
7.
Satue-Gracia E, Vila-Corcoles A, de Diego-Cabanes C, Vila-Rovira A, Torrente-Fraga C, Gomez-Bertomeu F, et al.
Med Clin (Engl Ed)
. 2022 May;
158(6):251-259.
PMID: 35492428
Objective: To analyse susceptibility/risk of suffering COVID-19 among adults with distinct underlying medical conditions. Methods: Population-based cohort study involving 79,083 individuals ≥50 years old in Tarragona (Southern Catalonia, Spain). Baseline...
8.
Perpinan C, Bertran L, Terra X, Aguilar C, Binetti J, Lopez-Dupla M, et al.
J Pers Med
. 2022 Mar;
12(3).
PMID: 35330391
The cytokine signature present in COVID-19 could provide information on the pathogenic mechanisms of the disease and could identify possible prognostic biomarkers and possible therapeutic targets. In this longitudinal work,...
9.
Yeregui E, Masip J, Vilades C, Domingo P, Pacheco Y, Blanco J, et al.
Int J Mol Sci
. 2022 Feb;
23(4).
PMID: 35216318
A significant proportion of people living with HIV (PLHIV) who successfully achieve virological suppression fail to recover CD4 T-cell counts. Since adipose tissue has been discovered as a key immune...
10.
Reverte L, Yeregui E, Olona M, Gutierrez-Valencia A, Buzon M, Marti A, et al.
Clin Transl Med
. 2022 Jan;
12(1):e704.
PMID: 35075803
No abstract available.